There are several NGS platforms and panels used by various studies (e.g., (i) FoundationOne assay, 324 gene panel—gene expression microarray technique, using HiSeq 2000 instrument to perform whole exome sequencing and tumor mutational burden calculation; (ii) 160 gene NGS panel with full coding sequence of SMARCA4 gene using MiSeq instrument with MiSeq Reagent Kit V3 (Illumina) and CLC Genomics Workbench Analysis Software (Qiagen); and (iii) Oncomine Cancer Research Panel (Oncomine Comprehensive Assay v3) covering 161 genes using Ion Chef and Ion S5 Systems (ThermoScientific) [6,7,19,28,35]). This evidence concerns the gene SMARCA4 and neoplasm.